These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26660184)

  • 1. High-Resolution Mass Spectrometry for Untargeted Drug Screening.
    Wu AH; Colby J
    Methods Mol Biol; 2016; 1383():153-66. PubMed ID: 26660184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry.
    Grapp M; Kaufmann C; Streit F; Binder L
    Forensic Sci Int; 2018 Jun; 287():63-73. PubMed ID: 29649771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
    Fels H; Dame T; Sachs H; Musshoff F
    Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening.
    Roman M; Ström L; Tell H; Josefsson M
    Anal Bioanal Chem; 2013 May; 405(12):4107-25. PubMed ID: 23455644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Broecker S; Herre S; Pragst F
    Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
    Ojanperä I; Kolmonen M; Pelander A
    Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology.
    Meyer GM; Maurer HH; Meyer MR
    Bioanalysis; 2016; 8(5):457-81. PubMed ID: 26924594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs.
    Helfer AG; Michely JA; Weber AA; Meyer MR; Maurer HH
    Anal Chim Acta; 2015 Sep; 891():221-33. PubMed ID: 26388381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine Multi-drug Screening with GC-MS or LC-MS-MS Using SALLE-hybrid PPT/SPE.
    Lee J; Park J; Go A; Moon H; Kim S; Jung S; Jeong W; Chung H
    J Anal Toxicol; 2018 Nov; 42(9):617-624. PubMed ID: 29762685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmortem drug screening by non-targeted and targeted ultra-performance liquid chromatography-mass spectrometry technology.
    Rosano TG; Wood M; Swift TA
    J Anal Toxicol; 2011 Sep; 35(7):411-23. PubMed ID: 21871149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Maurer HH
    Anal Bioanal Chem; 2007 Aug; 388(7):1315-25. PubMed ID: 17377775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-high resolution-tandem mass spectrometry using Orbitrap technology for comprehensive screening to detect drugs and their metabolites in blood plasma.
    Helfer AG; Michely JA; Weber AA; Meyer MR; Maurer HH
    Anal Chim Acta; 2017 May; 965():83-95. PubMed ID: 28366215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue?
    Trobbiani S; Stockham P; Scott T
    Drug Test Anal; 2017 Oct; 9(10):1630-1636. PubMed ID: 28207195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting.
    Pope JD; Black MJ; Drummer OH; Schneider HG
    Clin Biochem; 2021 Sep; 95():66-72. PubMed ID: 33989561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.
    Arnhard K; Gottschall A; Pitterl F; Oberacher H
    Anal Bioanal Chem; 2015 Jan; 407(2):405-14. PubMed ID: 25366975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS.
    Marin SJ; Hughes JM; Lawlor BG; Clark CJ; McMillin GA
    J Anal Toxicol; 2012 Sep; 36(7):477-86. PubMed ID: 22802572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.
    Meyer MR; Helfer AG; Maurer HH
    Bioanalysis; 2014 Aug; 6(17):2275-84. PubMed ID: 25383737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening analysis for medicinal drugs and drugs of abuse in whole blood using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS)--toxicological findings in cases of alleged sexual assault.
    Birkler RI; Telving R; Ingemann-Hansen O; Charles AV; Johannsen M; Andreasen MF
    Forensic Sci Int; 2012 Oct; 222(1-3):154-61. PubMed ID: 22770621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.